循環腫瘍細胞 (CTC) 診断市場は、2021 年の 19 億 941 万米ドルから 2028 年までに 36 億 5,638 万米ドルに達すると予測されています。 2021 年から 2028 年にかけて 9.7% の CAGR で成長すると推定されています。
循環腫瘍細胞 (CTC) は、がんの診断と治療において大きな可能性を秘めています。多くの技術が開発されており、CTC の検出、分離、濃縮、および分析の有効性を高めるために継続的に改善されています。 CTC の検出と分離に最もよく使用されるアプローチは、抗体が細胞表面抗原に選択的に結合する免疫ベースの検出です。腫瘍細胞は血液細胞とは異なる細胞表面マーカーを発現し、循環細胞から分離されています。 CTC は、最終的に治療抵抗性または疾患の再発を引き起こす可能性がある、一次組織に存在する細胞のマイナーなサブグループを検出するのに役立ちます。したがって、CTC の検出と特徴付けは、固形腫瘍悪性腫瘍の治療において避けられないステップになる可能性があります。
戦略的洞察
循環腫瘍細胞 ( CTC) 診断市場は、技術、アプリケーション、エンド ユーザー、および地理に基づいて分割されます。市場は、地理的に、北米、ヨーロッパ、アジア太平洋、中東およびアフリカ、南および中央アメリカに広く分割されています。このレポートは、市場の動向、技術の進歩、市場のダイナミクスなどのパラメーターを強調し、世界をリードする市場プレーヤーの競争状況の分析とともに、市場の洞察と詳細な分析を提供します。
循環腫瘍細胞 (CTC) 診断市場の有利な地域
市場の洞察
< h3>予測期間中の循環腫瘍細胞 (CTC) 診断市場の成長を促進するための低侵襲診断手順に対する需要の高まり
診断目的。非侵襲的手法を用いた循環腫瘍細胞診断により、がんの早期発見、変異の検出、治療中の腫瘍モニタリング、再発モニタリングが可能です。研究者は、循環腫瘍細胞を含む血液サンプルを使用して、固形腫瘍におけるすべての後成的および遺伝的変化を追跡できます。患者はこれらの検査のリスクが少なく、臨床医は簡単に複数回検査を行うことができます。患者は低侵襲手術を好みます。そのような手術で使用される高度な器具を使用すると、より繊細で複雑な作業をよりリスクが低く、痛みが少なく、傷跡が少ない状態で実行できるからです。
技術的な理由により実現可能性と処理時間の進歩、循環腫瘍細胞診断と液体生検は、癌患者の組織生検に代わる非侵襲的な代替手段として、最近かなりの関心を集めています。リキッドバイオプシーの採用は、改善された低侵襲のがん検出技術に関する理解が深まることによって促進されます。市場の成長は、非侵襲的ツールに対する需要の高まりと、CTC 検査およびリキッドバイオプシーの検査室での受け入れによって影響を受けるでしょう。リキッドバイオプシーは、医師が単純な血液サンプルから腫瘍に関するさまざまな情報を発見できるようにする、外科的生検に代わる非侵襲的でシンプルな方法です。血液検査は痛みがなく、非侵襲的で、リスクがなく、問題を診断するためのコストと時間を削減します。さらに、CTC、cfDNA、エキソソーム、およびマイクロベシクルを血液サンプルで検出できるため、血液ベースのリキッドバイオプシーがより普及しています。したがって、低侵襲診断検査に対する需要の増加が市場の成長に拍車をかけています。
Technology Insights
技術に基づいて、世界の循環腫瘍細胞 (CTC) 診断市場は、CTC 検出および濃縮法、CTC 直接検出法、および CTC 分析に分割されます。 2020 年には、CTC 検出および濃縮セグメントが市場で最大のシェアを占めました。さらに、同じセグメントは、2021年から2028年の間に市場で最高のCAGRを登録すると予想されています. CTC 診断の助けを借りて、個人を早期に診断することができます。したがって、これらのテクノロジーの適応が増加しており、予測期間中に市場を牽引すると予想されます。
アプリケーション インサイト
アプリケーションに基づいて、世界の循環腫瘍細胞 (CTC) 診断市場は臨床/リキッドバイオプシーに分岐し、リサーチ。 2020年には、研究セグメントが市場でより大きなシェアを占めており、同じセグメントは2021年から2028年の間に市場でより高いCAGRを記録すると予想されています.世界中でさまざまな病状の検出と診断が増加しているため、市場は将来的に成長すると予想されます。
エンドユーザーの洞察
エンドユーザーに基づいて、循環腫瘍細胞 (CTC) 診断市場は、病院と診療所、研究と学術機関、および診断センターに分割されます。研究および学術機関セグメントは、2021 年に最大の市場シェアを保持し、予測期間中に市場で最高の CAGR を登録すると予想されます。がん診断と治療法の開発に関する研究の増加、がん診断に関連する意識の高まり、および政府やその他の企業からの多額の投資は、研究および学術機関セグメントの市場成長を支える重要な要因の一部です。
技術別循環腫瘍細胞 (CTC) 診断市場 - 2021 年および 2028 年
製品の発売、および合併と買収は、世界の循環腫瘍細胞 (CTC) 診断市場のプレーヤーによって非常に採用されている戦略です。最近の主要な市場開発のいくつかを以下に示します。
- 2022 年 1 月、Thermo Fisher Scientific Inc. は、総額で PeproTech を完全に買収することを発表しました。約の購入価格。 18 億 5000 万米ドル。
- 2021 年 12 月、Epic Sciences, Inc. は、DefineMBC の発売を発表しました。DefineMBC は、細胞ベースおよび無細胞分析の両方を含む新しい転移性乳がん (MBC) 検査です。
COVID-19 のパンデミックは、がんに苦しむ人々とがんの監視能力に悪影響を及ぼしました。また、パンデミックにより、リソースとケアへの利用可能性が減少したため、がんの検出と治療が困難になり、死亡率が高くなり、生存率が低下しました。がんおよび/またはその治療によって引き起こされる免疫系の低下により、がん患者は感染性病原体 (手術や化学療法など) にかかりやすくなります。これにより、COVID-19 の問題と死亡率ががん患者に共通している可能性があるという懸念が高まっています。したがって、パンデミックは循環腫瘍細胞 (CTC) 診断市場に悪影響を及ぼします。
循環腫瘍細胞 (CTC) 診断 - 市場セグメンテーション
< p>世界の循環腫瘍細胞 (CTC) 診断市場は、技術、アプリケーション、エンドユーザー、地理に基づいて分割されています。技術面では、市場は CTC 検出および濃縮法、CTC 直接検出法、および CTC 分析に分割されます。アプリケーションに基づいて、世界の循環腫瘍細胞 (CTC) 診断市場は、臨床/リキッドバイオプシーと研究に分かれています。エンドユーザーに基づいて、循環腫瘍細胞 (CTC) 診断市場は、病院と診療所、研究と学術機関、および診断センターに分割されます。市場は、地理的に、北米、ヨーロッパ、アジア太平洋、中東およびアフリカ、南および中央アメリカに広く分割されています。
会社概要
< TIP>- Thermo Fisher Scientific Inc.
- STEMCELL Technologies Inc.
- QIAGEN
- Precision Medicine Group, LLC.
- Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)
- Epic Sciences
- ScreenCell
- Ikonisys, Inc.
- IVDiagnostics
- Fluxion Biosciences Inc0
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Global circulating tumor cell (CTC) diagnostics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The market growth in the country is attributed to the factors such as most foreign companies in the healthcare sector have R&D centres in the United States. Moreover, the increase in prevalence of cancer in the country along with various organic and inorganic developments done by the companies. And, Asia Pacific is the fastest-growing region growing at the CAGR of 10.3% during the forecast period.
The circulating tumor cell (CTC) diagnostics market majorly consists of the players such as Thermo Fisher Scientific, Stemcell Technologies, Inc, QIAGEN, Precision Medicine Group, LLC, Advanced Cell Diagnostics (Bio-Techne Corporation), Epic Lifesciences, Screencell, Ikonisys, Inc, IV Diagnostics, Fluxion Biosciences, among others
The research segment dominated the global circulating tumor cell (CTC) diagnostics market and accounted for the largest revenue share of 67.65% in 2021.
The CTC detection and enrichment method segment dominated the global circulating tumor cell (CTC) diagnostics market and held the largest revenue share of 62.85% in 2021.
Key factors that are driving the growth of this market are increasing prevalence of cancer across the globe along with rising demand for minimally invasive diagnostic procedures.
A Circulating Tumor Cell (CTC) is a cell that shed into lymphatics from the primary tumor and carried out throughout the body with blood circulation. Circulating tumor cells are the seeds for growth and metastases for additional tumors in distant organs and is responsible for majority of cancer related deaths. The diagnosis, detection and analysis of CTC can assist in patients’ prognoses determine appropriate tailored treatments for the patients. The CTC diagnosis has a lot of advantages for traditional diagnostic procedures. The advantages of CTC detection include, it is non-invasive, effective and can be used repeatedly. The CTC detection and enrichment, CTC direct detection and CTC analysis are the technologies used for CTC detection.
The List of Companies - Circulating Tumor Cell (CTC) Diagnostics Market
- Thermo Fisher Scientific Inc.
- STEMCELL Technologies Inc.
- QIAGEN
- Precision Medicine Group, LLC.
- Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)
- Epic Sciences
- ScreenCell
- Ikonisys, Inc.
- IVDiagnostics
- Fluxion Biosciences Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jan 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jan 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jan 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jan 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)